This inventor holds 1 USPTO granted patent. Top assignee: Molecure S.a.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Łukasz Krzemiński: Innovator in Therapeutic Applications
Introduction
Łukasz Krzemiński is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic applications related to chitinase-like protein YKL-40. His innovative work has the potential to impact various medical treatments and diagnostics.
Latest Patents
Krzemiński holds a patent for YKL-40 inhibitors and their therapeutic applications. The patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. Additionally, the patent identifies active compounds that serve as inhibitors of YKL-40, detailing their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. He has 1 patent to his name.
Career Highlights
Krzemiński is currently associated with Molecure S.A., a company focused on innovative drug development. His work at Molecure emphasizes the importance of YKL-40 in various therapeutic contexts, showcasing his commitment to advancing medical science.
Collaborations
He collaborates with notable colleagues, including Wojciech J Czestkowski and Marzena Mazur. Their combined expertise contributes to the innovative research and development efforts at Molecure.
Conclusion
Łukasz Krzemiński is a prominent figure in the field of therapeutic innovations, particularly concerning YKL-40 inhibitors. His contributions are paving the way for new medical advancements and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile